Arthroscopic Débridement for Knee Arthritis — Pure Placebo, So Medicare Stopped Paying in 2002

In July 2002, orthopedic surgeon J. Bruce Moseley and a Houston Veterans Affairs team reported in the New England Journal of Medicine that 180 patients with osteoarthritis of the knee, randomized double-blind to arthroscopic débridement, arthroscopic lavage, or a sham operation in which surgeons made skin incisions but inserted no instrument, had identical outcomes — and the gap between that finding and a decade of confident practice is the entire case. By 2002 the scope-and-clean operation for the arthritic knee was being performed on the order of 650,000 times a year in the United States at roughly $5,000 apiece, a multi-billion-dollar standard of care, on the mechanistic premise that flushing out debris and trimming frayed cartilage relieved pain. The trial showed it relieved nothing the placebo did not.

The harm here was not a body count of deaths but of unnecessary operations: hundreds of thousands of patients each year underwent a real surgery — anesthesia, incisions, infection risk, recovery, deductibles — to obtain a benefit indistinguishable from being wheeled into an operating room, cut, and sewn shut. At no point over two years of follow-up did either intervention group report less pain or better function than the sham group; the 95 percent confidence intervals excluded any clinically meaningful difference. The wonder of arthroscopy had been real for torn menisci and loose bodies, but for arthritis pain it was theater.

What makes the episode an exemplar of withdrawal is that it was killed by the right kind of evidence. Surgery had long been treated as exempt from the placebo-controlled standard demanded of drugs, on the assumption that an operation cannot ethically be faked. Moseley’s team did precisely that — and the result was so clean that the Centers for Medicare and Medicaid Services moved within a year to defund the procedure for osteoarthritis. A 2008 Canadian trial led by Alexandra Kirkley confirmed that arthroscopy added nothing to optimized physical and medical therapy, and by 2017 international guideline panels were issuing strong recommendations against it. The operation was never recalled or banned. It was disconfirmed, defunded, and abandoned — a textbook demonstration that a popular surgery can be a placebo, and that without a sham control no one would have known.